BRAF and melanoma: Both PHB ligands JI130 and MEL56 induce dose-dependent apoptosis in a panel of representative melanoma lines harboring wild-type BRAF and NRAS (HBL, LND1, and MM162), BRAF mutation (MM074 and MM029) or NRAS mutation (MM165) (Figure 3A).